Loading...
Cardlytics Inc (CDLX) is not a strong buy for a beginner investor seeking long-term growth at this time. The company's financials show significant declines in revenue, net income, and EPS, while technical indicators and trading signals do not suggest a favorable entry point. Additionally, there are no recent positive news or catalysts to support a bullish case.
The technical indicators for CDLX are mixed to bearish. The MACD is below zero and negatively contracting, RSI is neutral at 59.931, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its resistance level (R1: 1.011), with support at 0.825. Overall, no strong bullish signals are present.

Hedge funds have significantly increased their buying activity, with a 361.26% increase in the last quarter. Gross margin improved by 3.21% YoY to 45.27%.
No recent news or significant insider trading activity. The stock's technical indicators and financial performance do not support a strong bullish case.
In Q3 2025, Cardlytics reported a revenue decline to $52.03M (-22.41% YoY), net income dropped to -$72.67M (-49.94% YoY), and EPS fell to -1.36 (-53.10% YoY). Gross margin increased slightly to 45.27% (+3.21% YoY), but overall financial performance is weak.
No recent analyst ratings or price target changes are available for CDLX.